Related Experiment Video
Updated: Jul 26, 2026

06:57
Determining Viral Disinfection Efficacy of Hot Water Laundering
Published on: June 21, 2022
2.5K
Antiviral Efficacy Testing of a Rechargeable Textile
Mina Izadjoo1, Kylin Carhart1, Vanessa Marcel1
1Integrated Pharma Services, Rockville, MD 20850, USA.
Military Medicine
|August 20, 2024
Summary
Micrillon textiles demonstrate significant antiviral efficacy against Human Coronavirus OC43 and H1N1 Influenza A virus. This durable, chemical-free technology offers a reusable and sustainable solution for personal protective equipment, reducing viral transmission risks.
Area of Science:
- Textile Science
- Virology
- Materials Science
Background:
- The COVID-19 pandemic highlighted the critical need for effective personal protective equipment (PPE) to curb viral transmission.
- Human coronaviruses and influenza viruses present significant public health challenges due to their varied transmission routes.
- UMF Corporation developed Micrillon, a novel antiviral textile technology designed to be durable, chemical-free, and effective against viruses.
Purpose of the Study:
- To evaluate the antiviral efficacy of Micrillon-treated textiles against Human Coronavirus OC43 and H1N1 Influenza A virus.
- To assess the performance of Micrillon in various textile formats, including gloves, fabrics, and fibers.
- To determine the effectiveness of Micrillon technology in reducing viral load on treated materials over different contact times.
Main Methods:
- Testing was conducted according to ISO Standard 18184:2019.
- Micrillon textiles were challenged with Human Coronavirus OC43 and H1N1 Influenza A virus.
- Antiviral efficacy was quantified using Median Tissue Culture Infectious Dose (TCID50) assays on relevant cell lines (MDCK and HCT-8).
Main Results:
- Micrillon gloves achieved high antiviral efficacy, reducing H1N1 by 99.88% and OC43 by 99.67% within 120 minutes.
- Rolled Micrillon fabrics demonstrated strong efficacy, with 99.42% reduction against H1N1 at 30 minutes and over 97% against OC43 at all tested time points.
- Bundled Micrillon fibers showed substantial antiviral activity, achieving 99.17% reduction against H1N1 at 120 minutes and over 98% against OC43 across all time points.
Conclusions:
- Micrillon technology effectively inhibits viral activity on textiles, including gloves, fabrics, and fibers, against both Human Coronavirus and Influenza.
- The technology presents a reusable and sustainable alternative to conventional PPE, minimizing environmental impact and reducing reliance on harmful chemicals.
- Micrillon offers a promising solution for enhanced protection in healthcare and hospitality sectors, contributing to reduced infection risks with environmental consciousness.

